1-5 of 5
Cécile Gouttefangeas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PD-1 and LAG-3 Dominate Checkpoint Receptor–Mediated T-cell Inhibition in Renal Cell Carcinoma

Henning Zelba, Jens Bedke, Jörg Hennenlotter, Sven Mostböck, Markus Zettl, Thomas Zichner, Anoop Chandran, Arnulf Stenzl, Hans-Georg Rammensee, Cécile Gouttefangeas
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (11): 1891–1899.
https://doi.org/10.1158/2326-6066.CIR-19-0146
Published: 01 November 2019
View article titled, PD-1 and LAG-3 Dominate Checkpoint Receptor–Mediated T-cell Inhibition in Renal Cell Carcinoma
Open the PDF for PD-1 and LAG-3 Dominate Checkpoint Receptor–Mediated T-cell Inhibition in Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract B124: Personalized peptide vaccination based on patient-individual tumor-specific variants induces T-cell responses in pediatric patients

Armin Rabsteyn, Christina Kyzirakos, Christopher Schroeder, Marc Sturm, Christopher Mohr, Jakob Matthes, Magdalena Feldhahn, Nicolas Casadei, Martin Ebinger, Stefan Stevanovic, Peter Bauer, Oliver Kohlbacher, Cecile Gouttefangeas, Juergen Schaefer, Hans-Georg Rammensee, Rupert Handgretinger, Peter Lang
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (2_Supplement): B124.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-B124
Published: 01 February 2019
View article titled, Abstract B124: Personalized peptide vaccination based on patient-individual tumor-specific variants induces T-cell responses in pediatric patients
Journal Articles

Abstract A020: Immunomonitoring for actively personalized peptide vaccines (APVACs) during immunotherapeutic treatment of glioblastoma

Alexander Ulges, Norbert Hilf, Wolfgang Wick, Michael Platten, Pierre-Yves Dietrich, Katrin Frenzel, Arie Admon, Sjoerd S.H. van der Burg, Andreas von Deimling, Per thor Straten, Cecile Gouttefangeas, Judith R. Kroep, Francisco Martínez-Ricarte, Hideo Okada, Christian H. Ottensmeier, Berta Ponsati, Hans S. Poulsen, Stefan Stevanovic, Ghazaleh Tabatabai, Hans-Georg Rammensee, Ugur Sahin, Dominik Maurer, Regina Mendrzyk
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (2_Supplement): A020.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-A020
Published: 01 February 2019
View article titled, Abstract A020: Immunomonitoring for actively personalized peptide vaccines (APVACs) during immunotherapeutic treatment of glioblastoma
Journal Articles

Abstract A113: iVacALL: A personalized peptide-vaccination design platform for pediatric acute lymphoblastic leukemia patients based on patient-individual tumor-specific variants

Armin Rabsteyn, Christina Kyzirakos, Christopher Schröder, Marc Sturm, Christopher Mohr, Mathias Walzer, Ulrike Pflückhahn, Michael Walter, Magdalena Feldhahn, Karoline Laske, Michael Bonin, Martin Ebinger, Stefan Stevanovic, Peter Bauer, Oliver Kohlbacher, Cecile Gouttefangeas, Hans-Georg Rammensee, Rupert Handgretinger, Peter Lang
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): A113.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-A113
Published: 03 January 2016
View article titled, Abstract A113: iVacALL: A personalized peptide-vaccination design platform for pediatric acute lymphoblastic leukemia patients based on patient-individual tumor-specific variants
Journal Articles

Alternative Variants of Human HYDIN Are Novel Cancer-Associated Antigens Recognized by Adaptive Immunity

Karoline Laske, Yuriy V. Shebzukhov, Ludger Grosse-Hovest, Dmitry V. Kuprash, Svetlana V. Khlgatian, Ekaterina P. Koroleva, Alexey Y. Sazykin, Dmitry N. Penkov, Pavel V. Belousov, Stefan Stevanović, Verona Vass, Steffen Walter, David Eisel, Barbara D. Schmid-Horch, Sergei A. Nedospasov, Hans-Georg Rammensee, Cécile Gouttefangeas
Journal: Cancer Immunology Research
Cancer Immunol Res (2013) 1 (3): 190–200.
https://doi.org/10.1158/2326-6066.CIR-13-0079
Published: 08 September 2013
View article titled, Alternative Variants of Human <em>HYDIN</em> Are Novel Cancer-Associated Antigens Recognized by Adaptive Immunity
Open the PDF for Alternative Variants of Human <em>HYDIN</em> Are Novel Cancer-Associated Antigens Recognized by Adaptive Immunity in another window
Includes: Supplementary data